People with type 1 diabetes require insulin to live, while those with type 2 diabetes use insulin and other medications to ...

Under the new FDA guidelines, only people 65 and older and others with one or more health risk factors will be able to receive COVID-19 vaccinations. People considered healthy and under the age of 65 ...

CAMBRIDGE, MA / ACCESS Newswire / May 23, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it has submitted an ...

Moderna, Inc. (NASDAQ:MRNA) announced on Friday that it has submitted a marketing application to the U.S. Food and Drug ...

An FDA committee on Thursday recommended that COVID-19 vaccines for the 2025-2026 respiratory virus season — which, for the ...

In a major and controversial policy shift, the FDA announced in a New England Journal of Medicine article that updated ...

FDA's new COVID-19 vaccine policy may restrict low-risk individuals' access, pending clinical trials to prove benefits.

The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...

Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were instrumental in saving lives during the COVID pandemic.

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

Despite the fact that vaccines against COVID have already undergone strict safety reviews and that people continue to die ...

On May 22, an FDA advisory committee unanimously recommended COVID-19 vaccine manufacturers target the JN.1 variant in their formulations.  The Vaccines and Related Biological Products Advisory ...